In 1995: 10,283 units. In 1996: 16,473 units. In 1997: 23,304. In 1998: 27,736 units. Total: 77,796 units. Rate of refusal units: In 1995: 12.81%. In 1996: 10.67%. In 1997: 11.31%. In 1998: 17.78%. Reasons: HBsAg(+): 8.66%. Anti HCV (+): 3.17%. Anti HIV (+): 0.36%. VDRL (+): 1.04%. Malaria (+): 0.33%. Abnormal antibodies (+): 0.34%. High lipid in unit: 630 units (0.80%). Blood clotting: 10 units (0.01%).
Blood Donors ; Red Cross

civilian ; Red Cross ; In Blood

In the 88 cases of biliary disease, which was proven in Seoul Red Cross Hospital from Jan. 1980 to Dec. 1981,comparative studies were made with oral and IV cholecystocholangiographic findings and ultrasonographic findings.The resuslts were ; 1. In the 18 cases of GB stones, there are 17 cases (94.4%) of positive findings incholecysto-cholangiography with detection of stone in 7 cases (38.9%), while in sonographic study, 16 cases(88.9%) are shown positive findings with detection of stones in 11 cases (61.1%). 2. In the 17 cases of acalculouscholecystitis, the diagnostic accuracy is 88.2% in cholecystocholangiography and 64.7% in sonography. 3. In the 7cases of CBD stones, all cases are shown positive findings in cholecystocholangiography with detection of stone inonly one case (14.3%), while 6 cases (85.7%) of positive findings are shown in sonography with detection stone inall cases. 4. I.V. cholanagiography is more accurate diagnsotic procedure rather than oral GB study in the casesof poor or non-functioning GB. 5. Sonography is the choice of procedure in the diagnosis of stones, while in thecases of colecystitis, cholecystocholangiography is more useful diagnostic procedure.
Diagnosis ; Red Cross ; Seoul ; Ultrasonography

BACKGROUND: An unexpected antibody screening test with panel cells from abroad without Dia positive cells is common practice in most laboratories in Korea, although it is impossible to detect anti-Dia. Our laboratory have used DiaCell Dia (DiaMed Ag, Cressier, Morat, Switzerland) as one of antibody screening panel cells and only positive samples with DiaCell Dia cells have been also confirmed with Dia antigen positive panel cells from Korean Red Cross (KRC). In this study, the experiences and clinical usefulness of DiaCell Dia were evaluated. METHODS: The 26,102 pretransfusion samples were tested by DiaMed microcolumn gel assay using the LISS/Coombs card, ID-DiaCell I, II, and DiaCell Dia. The DiaMed microcolumn gel assay using the LISS/Coombs card has been used for unexpected antibody screening test with panel cells from KRC. RESULTS: The positive detection rate of unexpected antibody screening test using ID-DiaCell I and II was 0.58%(151/26, 102), and eleven samples were reactive (1+~2+) with DiaCell Dia panel cells (0.04%). However, only six(0.02%) of 11 samples were reactive(2+) with Dia positive cells from KRC. CONCLUSION: The discrepant detection rate for unexpected antibody with Dia panel cells between from DiaMed and KRC is supposed to need further study. The addition of Dia positive cells as an unexpected antibody screening panel cells is strongly recommended in case that antiglobulin phase of crossmatch is abbreviated for unimmunized patients.
Humans ; Korea ; Mass Screening* ; Red Cross

This series represents 128 cases of acute gonococcal urethritis treated with doxycycline at the Seoul Red Cross Hospital from the 1st. May to.5th, Oct., 1969. Results of this treatment were divided in three groups: Group I ; Single dose of doxycycline, 300 mg. was administered for this group. 36 cases fall into this category. Cure rate for this group was 36%. Group II; Doxycycline, 200mg. was given on the 1st treatment day and daily dose of 100 mg. for 4 ensuing days. 42 cases were included to this group. Cure rate was 72%. Group III Daily dose of 200 mg. was administered for the remainders, 50 cases for 5 consecutive days. Cure rate was 91%. It was concluded that 200 mg. of doxycycline daily for 5 days dose regime can be recommended for the treatment of acute gonococcal urethritis, especially in cases allergic to penicillin or in which penicillin treatment fails. No anaphylactic shock or some other undesirable side reaction in administering this drug was experienced.
Anaphylaxis ; Doxycycline ; Penicillins ; Red Cross ; Seoul ; Urethritis

BACKGROUD: The blood component should not be issued for transfusion if there is any abnormality in color or physical appearance, or any indication of contamination. During 3 years (1999-2001), 1,041 blood components were returned to Central Red Cross Blood Center from the hospitals because of various reasons. We Analyzed the frequency and reasons of blood component returns for the useful information of blood supply plan. METHODS: Each blood component return in the Blood Component Return Report from 1999 through 2001 was examined for the number of units and return reasons. RESULTS: For 3 years, the total number of supplied blood components were 1,203,573 units and 1,041 (0.09%) of them were returned from 26 hospitals. The most common reason of return was broken bag or pilot tube (70.9%). Other reasons were fibrin(or precipitates) in bag (3.0%), clots in pilot tube (2.9%), turbid plasma (1.8%), hemolysis (0.5%), icteric plasma (0.3%), label errors (1.1%), incompatible cross matching (0.2%) and others (0.7%). Also there were blood returns due to poor handling of blood components in hospital (1.9%) and reasons unrelated to blood safety, purity and potency such as rare blood (5.8%), exchange for fresh blood (9.8%) and unused blood (1.2%). The most commonly returned blood component was plasma component (69.5% of units) CONCLUSION: The final product should be inspected prior to issue with more strict standard. And the proper system for assurance of returned normal blood components from hospitals must be applied for efficient blood utilization.
Blood Safety ; Hemolysis ; Plasma ; Red Cross

A statistical observation was made on 325 in-patients with age distribution, disease entities and operative procedures in the Department of Urology, Seoul Red Cross Hospital, during the period from January 1st 1977 to December 31st 1979.
Age Distribution ; Red Cross ; Seoul ; Surgical Procedures, Operative ; Urology

BACKGROUND: All donated bloods collected by the Korean Red Cross Blood Centers are tested for anti-HCV (Hepatitis C Virus) antibody by enzyme immunoassay (EIA) kits made in Korea. EIA test has sustaining problem of false positivity in spite of great progress in manufacturing kits. So, many healthy donors have been reported as being infected with HCV and excluded from next donation. METHODS: Among blood samples of 2,040,151 donors which were tested by two kinds of EIA kits (DONG-A HCV 3.0 and LG HCD 3.0) from 16 blood centers during 12 months, repeatably reactive samples, total 6,851 samples, were supplementally tested by LG HCD CONFIRM immunoblot test. RESULTS: Positive, indeterminate and negative rate in immunoblot tests were 39%, 9%, and 12% respectively among 6,851 repeatably reactive samples. Estimated true positive rate of anti-HCV antibody in Korean blood donors was 0.13%, showing geographical difference between 0.03% and 0.46%. Of EIA repeatably reactive samples, 28% showed greater than 5 signal to cutoff (S/C) ratio and most of them (94%) was revealed to be positive. CONCLUSION: True positive rate of EIA test results is so low that it would be necessary to increase the confidence of such results by immunoblot tests.
Blood Donors* ; Humans ; Immunoenzyme Techniques ; Korea ; Red Cross ; Tissue Donors

BACKGROUND: Only 39% was the positive predictive value of anti-hepatitis C virus (HCV) antibody test done by Korean Red Cross. Supplemental enzyme immunoassay (EIA) by another EIA kit may be also effective for reporting the more correct result to donors, instead of expensive supplemental immunoblot test. METHODS: All repeatedly reactive blood samples by EIA from 16 regional blood centers were retested for anti-HCV antibody by Abbott IMx HCV kit and LG HCD CONFIRM immunoblot kit. Presence of viral RNA was also confirmed using Amplicor HCV TEST kit from 180 samples, which were proportionately selected according to supplemental EIA and Immunoblot results. RESULTS: Of 2,211 repeatedly reactive samples, 909 samples (41%) were reactive and 1,302 (59%) samples were non-reactive with IMx HCV kit. 81% of reactive samples also showed positive pattern on the LG HCD CONFIRM strips and 79% of 1,302 samples showed negative pattern. RNA positivity was estimated 66% and 17% in Abbott IMx HCV positive and negative samples respectively, and 72%, 6%, 20% in LG HCD CONFIRM positive, indeterminate and negative samples respectively. CONCLUSION: HCV RNA positivity in positive samples by Abbott IMx HCV or LG HCD CONFIRM was not statistically significant (z=0.57 < 1.96, alpha=0.05). RNA detection rate by Abbott IMx HCV or LG HCD CONFIRM among HCV RNA positive samples, which was estimated as 73%, 70% respectively, was also statistically insignificant (z=0.375 < 1.96, alpha=0.05). So, it seems to be a good and economical practice that donors are notified of anti-HCV antibody results after supplemental EIA test using Abbott IMx HCV kit.
Humans ; Immunoenzyme Techniques* ; Red Cross ; RNA ; RNA, Viral ; Tissue Donors*

The cystoscopic manipulation was applied in 35 cases of lower third ureteral stones who visited the Department of Urology Red Cross Hospital during the period of 2 years 4 months from March 1st, 1980 to June 31th, 1982, using wooven loop stone dislodger and dormia stone dislodger and following result were obtained. A)With dormia stone dislodger. 1. In 8 cases, low third ureteral stones were extruded immediately and 2 lower third ureteral stones were delivered spontaneously after cystoscopic manipulation. 2. In 3 cases, dormia stone dislodger could not by pass the stones. B)With woven stone dislodger. 1. In 9 cases, lower third ureteral stones were extracted immediately and 4 lower third ureteral stones were delivered spontaneously after cystoscopic manipulation. 2. In 2 cases, wooven stone dislodger could not by pass the stones. 3. There were no major complications but minor complications occurred such as fever, flank pain and gross hematuria.
Cystoscopy ; Endoscopy ; Fever ; Flank Pain ; Hematuria ; Red Cross ; Ureter* ; Urology